UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036686
Receipt number R000041794
Scientific Title Elucidation of disease by outflow dynamics imaging of bile and pancreatic fluid using cinedynamic MRI
Date of disclosure of the study information 2019/05/10
Last modified on 2022/05/31 19:42:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Elucidation of disease by outflow dynamics imaging of bile and pancreatic fluid using cinedynamic MRI

Acronym

Elucidation of disease by outflow dynamics imaging of bile and pancreatic fluid using cinedynamic MRI

Scientific Title

Elucidation of disease by outflow dynamics imaging of bile and pancreatic fluid using cinedynamic MRI

Scientific Title:Acronym

Elucidation of disease by outflow dynamics imaging of bile and pancreatic fluid using cinedynamic MRI

Region

Japan


Condition

Condition

Chronic pancreatitis, Autoimmune pancreatitis,Sphincter of Oddi dysfunction

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In patients with suspected biliary and pancreatic fluid outflow disorders (pathology), use cinedynamic MRI to investigate whether pancreatic fluid and biliary outflow disorders can be diagnosed.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Comparison of biliary and pancreatic fluid outflow in cinedynamic MRCP in healthy volunteer groups and disease groups suspected of biliary and pancreatic fluid outflow disorders.

Key secondary outcomes

Evaluation of outflow capacity according to disease. Diagnosis and evaluation after duodenal papillary sphincter dysfunction.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

One MRI examination is performed on a group of healthy volunteers.

Interventions/Control_2

Disease group is usually examined in the medical practice.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients suspected of bile or pancreatic fluid outflow disorder by other imaging tests.
Patients who obtained written consent by their own intention about participation in this study.

Key exclusion criteria

Patients whose MRI images are difficult to evaluate due to artifacts.
Patients who could not carry out MRI examination for some reason.
Patients who were judged inappropriate by the person in charge of this study.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Atsuhiro
Middle name
Last name Masuda

Organization

Kobe University

Division name

Gastroenterology

Zip code

650-0017

Address

7-5-1 Kusunoki-cho,Chuo-ku,Kobe,650-0017,Japan

TEL

078-382-6305

Email

atmasuda@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name Shigeto
Middle name
Last name Ashina

Organization

Kobe University

Division name

Gastroenterology

Zip code

650-0017

Address

7-5-1 Kusunoki-cho,Chuo-ku,Kobe,650-0017,Japan

TEL

078-382-6305

Homepage URL


Email

sashina@med.kobe-u.ac.jp


Sponsor or person

Institute

Kobe University

Institute

Department

Personal name



Funding Source

Organization

Kobe University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kobe University

Address

7-5-1 Kusunoki-cho,Chuo-ku,Kobe,650-0017,Japan

Tel

078-382-6669

Email

kainyu@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 05 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

32

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 05 Month 08 Day

Date of IRB

2019 Year 10 Month 31 Day

Anticipated trial start date

2019 Year 06 Month 01 Day

Last follow-up date

2022 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 05 Month 08 Day

Last modified on

2022 Year 05 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041794


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name